SSY Stock Overview
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
SunLink Health Systems, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.70 |
52 Week High | US$1.11 |
52 Week Low | US$0.54 |
Beta | 1.36 |
1 Month Change | -7.10% |
3 Month Change | -22.70% |
1 Year Change | -33.73% |
3 Year Change | -68.23% |
5 Year Change | -58.34% |
Change since IPO | -91.81% |
Recent News & Updates
Shareholder Returns
SSY | US Healthcare | US Market | |
---|---|---|---|
7D | 0.8% | 6.5% | -3.2% |
1Y | -33.7% | 4.0% | 19.3% |
Return vs Industry: SSY underperformed the US Healthcare industry which returned 4% over the past year.
Return vs Market: SSY underperformed the US Market which returned 19.3% over the past year.
Price Volatility
SSY volatility | |
---|---|
SSY Average Weekly Movement | 5.0% |
Healthcare Industry Average Movement | 6.9% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SSY's share price has been volatile over the past 3 months.
Volatility Over Time: SSY's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1959 | n/a | Robert Thornton | www.sunlinkhealth.com |
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre.
SunLink Health Systems, Inc. Fundamentals Summary
SSY fundamental statistics | |
---|---|
Market cap | US$5.14m |
Earnings (TTM) | -US$4.16m |
Revenue (TTM) | US$46.93m |
0.1x
P/S Ratio-1.2x
P/E RatioIs SSY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SSY income statement (TTM) | |
---|---|
Revenue | US$46.93m |
Cost of Revenue | US$44.26m |
Gross Profit | US$2.67m |
Other Expenses | US$6.83m |
Earnings | -US$4.16m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.59 |
Gross Margin | 5.68% |
Net Profit Margin | -8.87% |
Debt/Equity Ratio | 0% |
How did SSY perform over the long term?
See historical performance and comparison